Nicole LaBrosse, SVP, CFO: Halozyme Therapeutics HALO Sell · Filed 25/09/11

Trade details

Type: Insider sale
Amount: $508,960.4
Shares · price: 6,760 sh · $75.29 a share
Held after: 37,546 sh
Stock: Halozyme Therapeutics HALO
Person: Nicole LaBrosseSVP, CFO
Trade date: 25/09/10
Filed: 25/09/11
Days to filing: 1 days

Sold 15.3% of holdings

Share of holding sold: 15.3%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/11~25/10/10

Nicole LaBrosse's recent trades

Nicole LaBrosseSVP, CFO
Planned saleHalozyme Therapeutics
Planned sale
Halozyme Therapeutics
HALO
$986.6K
14,700 sh
$986.6K
Filed 05/15
Traded 05/15
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$148.9K
1,913 sh
$148.9K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$24.7K
314 sh
$24.7K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1M
13,240 sh
$1M
Filed 25/09/11
Traded 25/09/10
Nicole LaBrosseSVP, CFO
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$1.7M
22,227 sh
$1.7M
Filed 25/09/10
Traded 25/09/10